新日本製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 化学 | 4931/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/07/12 | 日証協 | 155,458株 | +3.94% | 299,267株 | +62.6% | 754,182株 | +0.39% | 32,502株 | +8.98% |
| 2024/07/05 | 日証協 | 149,558株 | +51.59% | 184,048株 | -42.96% | 751,279株 | +10.3% | 29,824株 | -92.44% |
| 2024/06/28 | 日証協 | 98,658株 | -26.46% | 322,670株 | +21.14% | 681,106株 | +47.22% | 394,471株 | +59.06% |
| 2024/06/21 | 日証協 | 134,158株 | +11.56% | 266,370株 | +47.76% | 462,632株 | +99.21% | 247,998株 | +950.44% |
| 2024/06/14 | 日証協 | 120,258株 | +15.13% | 180,270株 | +107.16% | 232,232株 | +8.04% | 23,609株 | +23.83% |
| 2024/06/07 | 日証協 | 104,458株 | +20.54% | 87,018株 | +242.28% | 214,950株 | +5.12% | 19,066株 | +68.83% |
| 2024/05/31 | 日証協 | 86,658株 | -3.78% | 25,423株 | +9999.99% | 204,488株 | -1.58% | 11,293株 | -9.64% |
| 2024/05/24 | 日証協 | 90,058株 | +0.22% | 200株 | -93.89% | 207,772株 | -20.7% | 12,498株 | -5.4% |
| 2024/05/17 | 日証協 | 89,858株 | -4.74% | 3,272株 | 0% | 262,001株 | -0.38% | 13,212株 | +33.48% |
| 2024/05/10 | 日証協 | 94,329株 | -2.88% | 0株 | 0% | 263,008株 | +0.04% | 9,898株 | +76% |
| 2024/05/02 | 日証協 | 97,129株 | -2.31% | 0株 | -100% | 262,913株 | -0.03% | 5,624株 | -63.75% |
| 2024/04/26 | 日証協 | 99,429株 | +7.34% | 10,300株 | 0% | 263,002株 | +4.25% | 15,513株 | -31.05% |
| 2024/04/19 | 日証協 | 92,629株 | -9.03% | 0株 | -100% | 252,288株 | -1.4% | 22,498株 | +127.09% |
| 2024/04/12 | 日証協 | 101,829株 | -8.04% | 23,974株 | -25.02% | 255,882株 | -2.18% | 9,907株 | +14.33% |
| 2024/04/05 | 日証協 | 110,729株 | -7.65% | 31,974株 | -75.59% | 261,581株 | +103.94% | 8,665株 | -93.67% |
| 2024/03/29 | 日証協 | 119,895株 | +3.72% | 130,996株 | +12.67% | 128,264株 | -51.08% | 136,781株 | +968.6% |
| 2024/03/22 | 日証協 | 115,595株 | -10.13% | 116,267株 | +12.33% | 262,180株 | -0.59% | 12,800株 | +35.46% |
| 2024/03/15 | 日証協 | 128,624株 | -23.54% | 103,509株 | +82.65% | 263,745株 | -1.37% | 9,449株 | -60.65% |
| 2024/03/08 | 日証協 | 168,224株 | -2.51% | 56,672株 | 0% | 267,404株 | +1.91% | 24,015株 | +246.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top